Tara I. Chang

Stanford University Professor of Nephrology

Bio

Tara Chang, MD, MS is a board-certified nephrologist who enjoys taking care of patients with all types of kidney diseases. She is also a certified Hypertension Specialist, and has a particular interest in treating patients with high blood pressure. In addition to her patient care duties, Dr. Chang maintains an active clinical research program, which focuses on studying cardiovascular disease in patients with chronic kidney disease. She has received grant funding from the National Institutes of Health and the American Heart Association.

Dr. Chang speaks conversational Mandarin. She enjoys jogging, yoga, and spending time with her husband, son and twin daughters.

Clinical Focus

Nephrology
hypertension
chronic kidney disease
dialysis

Academic Appointments

Professor - University Medical Line, Medicine - Nephrology
Member, Cardiovascular Institute

Administrative Appointments

Division Chief, Stanford Division of Nephrology (2021 - Present)
Director of Clinical Research, Stanford Division of Nephrology (2016 - 2021)

Professional Education

Board Certification: American Board of Internal Medicine, Internal Medicine (2020)
Board Certification: American Board of Internal Medicine, Nephrology (2020)
Residency: University of California San Francisco Internal Medicine Residency (2006) CA
Fellowship: Stanford University Division of Nephrology (2009) CA
Medical Education: University of Michigan Health System (2003) MI

Contact

Academic tichang@stanford.edu

Administrative Operations Coordinator Alexandra Bibby Administrative Operations Coordinator abibby@stanford.edu Tel: 650-497-3036

Clinical (Primary)

This is the primary clinic for this clinical provider. For additional clinical locations and information, please visit the link(s) listed below in the 'Additional Clinical Info' section.

Kidney Clinic 300 Pasteur Dr Rm A11 MC 5309 Stanford CA 94305 Tel: (650) 723-6961 Fax: (650) 725-8418

Additional Clinical Info

Stanford Health Care

Current Research and Scholarly Interests

As a board-certified nephrologist, I see first-hand the pervasiveness of cardiovascular disease in patients with chronic kidney disease (CKD). As a trained epidemiologist and clinical researcher, I also see the lack of evidence available to guide treatment decision-making in CKD. Motivated by these evidence gaps, my research seeks to clarify questions about cardiovascular care in patients with CKD. My research specifically focuses on issues such as blood pressure control, coronary revascularization, and the comparative effectiveness of cardioprotective medications in patients with CKD, with the long-term goal of improving outcomes in these high-risk patients.

Clinical Trials

Comparing Diuretic Strategies in Hospitalized Heart Failure Not Recruiting
More
We will conduct a pragmatic randomized trial comparing whether using a combination of two types of diuretics (loop + thiazide) compared with using a single diuretic (loop only) will result in shorter hospital stays for patients hospitalized with heart failure.

Stanford is currently not accepting patients for this trial. For more information, please contact SPECTRUM, .

Lead Sponsor
- Stanford University
Stanford Investigators
- Tara I. Chang
View full details
CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™ Recruiting
More
The objective of this study is to evaluate the safety and effectiveness of the MobiusHD System in a prospective, randomized, double-blind, sham-controlled multi-center pivotal study.
Lead Sponsor
Stanford Investigators
- Tara I. Chang
View full details

2023-24 Courses

Independent Studies
- Medical Scholars Research
  MED 370 (Aut, Win, Spr, Sum)

Stanford Advisees

Postdoctoral Faculty Sponsor
Ali Etemadi

All Publications

Profiles With Related Publications

close
Alyce Sophia Adams

Stanford Medicine Innovation Professor and Professor of Epidemiology and Population Health, of Health Policy and, by courtesy, of Pediatrics (Endocrinology)

117 Total Publications
close
Brian T. Bateman

Anesthesiology, Perioperative and Pain Medicine Professor and Professor, by courtesy, of Epidemiology and Population Health
Clinical Focus
Anesthesia

474 Total Publications
close
Glenn M. Chertow

Norman S. Coplon/Satellite Healthcare Professor of Medicine and Professor, by courtesy, of Epidemiology and Population Health and of Health Policy
Clinical Focus
Nephrology
Research Interests
clinical epidemiology, health services research, decision sciences, clinical trials in acute and chronic kidney disease

992 Total Publications
close
Enrica Fung, MD

Clinical Assistant Professor, Medicine - Nephrology
Clinical Focus
Nephrology

7 Total Publications
close
Robert Harrington

Arthur L. Bloomfield Professor of Medicine, Emeritus

726 Total Publications
close
Paul Heidenreich, MD

Professor of Medicine (Cardiovascular)
Clinical Focus
Echocardiography, Cardiovascular Disease
Research Interests
My research interests include

1) The cost-effectiveness of new cardiovascular technologies.
Example: tests to screen asymptomatic patients for left ventricular systolic dysfunction.

2) Interventions to improve the quality of care of patients with heart disease. Examples: include clinical reminders and home monitoring.

3) Outcomes research using existing clinical and administrative datasets.

4) Use of echocardiography to predict prognosis (e.g. diastolic dysfunction).

936 Total Publications
close
Mark Hlatky, MD

Professor of Health Policy, of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Research Interests
My main research work is in "outcomes research", especially examining the field of cardiovascular medicine. Particular areas of interest are the integration of economic and quality of life data into randomized clinical trials, evidence-based medicine, decision models, and cost-effectiveness analysis. I am also interested in the application of novel genetic, biomarker, and imaging tests to assess risk and guide clinical management of coronary artery disease.

423 Total Publications
close
Jane P. Kim

Clinical Associate Professor, Psychiatry and Behavioral Sciences
Research Interests
Dr. Kim’s research focuses on applying statistical approaches to evaluate and improve digital interventions, and using empirical approaches to understand ethical considerations for AI applications in healthcare.

60 Total Publications
close
Philip W. Lavori

Professor of Biomedical Data Science, Emeritus
Research Interests
Biostatistics, clinical trials, longitudinal studies, casual inference from observational studies, genetic tissue banking, informed consent. Trial designs for dynamic (adaptive) treatment regimes, psychiatric research, cancer.

342 Total Publications
close
Colin Lenihan

Clinical Associate Professor, Medicine - Nephrology
Clinical Focus
Nephrology, Kidney Transplant

49 Total Publications
close
David J. Maron

C. F. Rehnborg Professor and Professor of Medicine (Stanford Prevention Research Center)
Clinical Focus
Cardiovascular Disease, Coronary Artery Disease, Angina, High Cholesterol, Familial Hypercholesterolemia, Coronary Artery Calcification, Primary Prevention, Secondary Prevention, Chest Pain
Research Interests
Dr. Maron is the Co-Chair and Principal Investigator of the ISCHEMIA trial, and Co-Chair of the ISCHEMIA-CKD trial. These large, international, NIH-funded studies will determine whether an initial invasive strategy of cardiac catheterization and revascularization plus optimal medical therapy will reduce cardiovascular events in patients with and without chronic kidney disease and at least moderate ischemia compared to an initial conservative strategy of optimal medical therapy alone.

220 Total Publications
close
Timothy Meyer

Stanford University Professor of Nephrology, Emeritus
Research Interests
Inadequate removal of uremic solutes contributes to widespread illness in the more than 500,000 Americans maintained on dialysis. But we know remarkably little about these solutes. Dr. Meyer's research efforts are focused on identifying which uremic solutes are toxic, how these solutes are made, and how their production could be decreased or their removal could be increased. We should be able to improve treatment if we knew more about what we are trying to remove.

150 Total Publications